OpGen Inc
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, includ… Read more
OpGen Inc (OPGN) - Total Liabilities
Latest total liabilities as of September 2025: $2.48 Million USD
Based on the latest financial reports, OpGen Inc (OPGN) has total liabilities worth $2.48 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
OpGen Inc - Total Liabilities Trend (2012–2025)
This chart illustrates how OpGen Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
OpGen Inc Competitors by Total Liabilities
The table below lists competitors of OpGen Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lokum Deweloper SA
WAR:LKD
|
Poland | zł293.75 Million |
|
SoftOx Solutions AS
OL:SOFTX
|
Norway | Nkr17.26 Million |
|
Mitrabara Adiperdana PT
JK:MBAP
|
Indonesia | Rp54.08 Million |
|
United Express Inc
PINK:UNXP
|
USA | $1.18 Million |
|
Allcargo Terminals Ltd
NSE:ATL
|
India | ₹7.74 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down OpGen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how OpGen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for OpGen Inc (2012–2025)
The table below shows the annual total liabilities of OpGen Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $2.48 Million | 0.00% |
| 2024-12-31 | $2.48 Million | -81.54% |
| 2023-12-31 | $13.44 Million | -26.35% |
| 2022-12-31 | $18.25 Million | -40.05% |
| 2021-12-31 | $30.45 Million | +6.62% |
| 2020-12-31 | $28.56 Million | +366.02% |
| 2019-12-31 | $6.13 Million | +8.63% |
| 2018-12-31 | $5.64 Million | +8.10% |
| 2017-12-31 | $5.22 Million | -10.27% |
| 2016-12-31 | $5.82 Million | -7.26% |
| 2015-12-31 | $6.27 Million | -41.50% |
| 2014-12-31 | $10.72 Million | +114.83% |
| 2013-12-31 | $4.99 Million | +103.89% |
| 2012-12-31 | $2.45 Million | -- |